Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons

Liver transplantation (LT) has emerged as a curative strategy for hepatocellular carcinoma (HCC), but contributes to a higher predisposition to HCC recurrence in the immunosuppression context, especially for tumors beyond the Milan criteria. Although immunotherapy has dramatically improved survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yi, Teng, Fei, Fu, Hong, Ding, Guo-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790424/
https://www.ncbi.nlm.nih.gov/pubmed/35116109
http://dx.doi.org/10.4251/wjgo.v14.i1.163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790424/
https://www.ncbi.nlm.nih.gov/pubmed/35116109
http://dx.doi.org/10.4251/wjgo.v14.i1.163

Ejemplares similares